BJP CPD Online e-learning site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

The British Journal of Psychiatry (1968) 114: 345-350. doi: 10.1192/bjp.114.508.345
© 1968 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SHAPIRO, A. K.
Right arrow Articles by SHAPIRO, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SHAPIRO, A. K.
Right arrow Articles by SHAPIRO, E.

Treatment of Gilles de la Tourette's Syndrome with Haloperidol

ARTHUR K. SHAPIRO M.D.1 and ELAINE SHAPIRO PH.D.2

1 Clinical Associate Professor, Department of Psychiatry, The New York Hospital—Cornell Medical Center (Payne Whitney Psychiatric Clinic), 525 East 68th Street, New York, New York 10021
2 Mount Vernon Mental Health Clinic, Community Mental Health Board, Mount Vernon, New York

This paper described one detailed and two brief reports of patients with Gilles de la Tourette's syndrome successfully treated with haloperidol. It is likely that the aetiology of the syndrome is organic pathology of the central nervous system, and possible that psychological characteristics are secondary effects of the illness.

Submitted on March 20, 1967




This article has been cited by other articles:


Home page
 BrainHome page
M. M. Robertson
Tourette syndrome, associated conditions and the complexities of treatment
Brain, March 1, 2000; 123(3): 425 - 462.
[Abstract] [Full Text] [PDF]

Home page
 PsychosomaticsHome page
Academy of Psychosomatic Medicine: Proceedings of the 45th Annual Meeting: November 19–22, 1998, Lake Buena Vista (Orlando), FL
Psychosomatics, April 1, 1999; 40(2): 135 - 178.
[Full Text]

Home page
 Arch Gen PsychiatryHome page
A. K. Shapiro, E. Shapiro, and H. Wayne
Treatment of Tourette's Syndrome: With Haloperidol, Review of 34 Cases
Arch Gen Psychiatry, January 1, 1973; 28(1): 92 - 97.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
H. Kazamatsuri, C.-p. Chien, and J. O. Cole
Therapeutic Approaches to Tardive Dyskinesia: A Review of the Literature
Arch Gen Psychiatry, October 1, 1972; 27(4): 491 - 499.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
H. Kazamatsuri, C.-p. Chien, and J. O. Cole
Treatment of Tardive Dyskinesia: II. Short-Term Efficacy of Dopamine-Blocking Agents Haloperidol and Thiopropazate
Arch Gen Psychiatry, July 1, 1972; 27(1): 100 - 103.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1968 The Royal College of Psychiatrists.